Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P et al (2020) 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 76(25):e159–e240

Article  PubMed  Google Scholar 

Marian AJ, Braunwald E (2017) Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res 121(7):749–770

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lehman SJ, Crocini C, Leinwand LA (2022) Targeting the sarcomere in inherited cardiomyopathies. Nat Rev Cardiol 19(6):353–363

Article  PubMed  PubMed Central  Google Scholar 

Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE (1995) Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 92(4):785–789

Article  CAS  PubMed  Google Scholar 

Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS (2014) Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. J Am Coll Cardiol 64(1):83–99

Article  PubMed  Google Scholar 

Maron MS, Hellawell JL, Lucove JC, Farzaneh-Far R, Olivotto I (2016) Occurrence of clinically diagnosed hypertrophic cardiomyopathy in the United States. Am J Cardiol 117(10):1651–1654

Article  PubMed  Google Scholar 

Semsarian C, Ingles J, Maron MS, Maron BJ (2015) New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol 65(12):1249–1254

Article  PubMed  Google Scholar 

Mazzarotto F, Olivotto I, Boschi B, Girolami F, Poggesi C, Barton PJ et al (2020) Contemporary insights into the genetics of hypertrophic cardiomyopathy: toward a new era in clinical testing? J Am Heart Assoc 9(8):e015473

Article  CAS  PubMed  PubMed Central  Google Scholar 

Watkins H (2021) Time to think differently about sarcomere-negative hypertrophic cardiomyopathy. Circulation 143(25):2415–2417

Article  PubMed  Google Scholar 

Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT et al (2006) Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114(21):2232–2239

Article  PubMed  Google Scholar 

Stewart S, Mason DT, Braunwald E (1968) Impaired rate of left ventricular filling in idiopathic hypertrophic subaortic stenosis and valvular aortic stenosis. Circulation 37(1):8–14

Article  CAS  PubMed  Google Scholar 

Maron BJ, Rowin EJ, Maron MS (2019) Letter by Maron et al regarding article, “genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the sarcomeric human cardiomyopathy registry (SHaRe).” Circulation 139(12):1557–1558

Article  PubMed  Google Scholar 

Capota R, Militaru S, Ionescu AA, Rosca M, Baicus C, Popescu BA et al (2020) Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire. Health Qual Life Outcomes 18:1–8

Article  Google Scholar 

Guttmann OP, Rahman MS, O’Mahony C, Anastasakis A, Elliott PM (2014) Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review. Heart 100(6):465–472

Article  PubMed  Google Scholar 

Ho CY, Day SM, Ashley EA, Michels M, Pereira AC, Jacoby D et al (2018) Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe). Circulation 138(14):1387–1398

Article  PubMed  PubMed Central  Google Scholar 

Marstrand P, Han L, Day SM, Olivotto I, Ashley EA, Michels M et al (2020) Hypertrophic cardiomyopathy with left ventricular systolic dysfunction: insights from the SHaRe registry. Circulation 141(17):1371–1383

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spirito P, Autore C, Rapezzi C, Bernabò P, Badagliacca R, Maron MS et al (2009) Syncope and risk of sudden death in hypertrophic cardiomyopathy. Circulation 119(13):1703–1710

Article  PubMed  Google Scholar 

Maron BJ, Shen W-K, Link MS, Epstein AE, Almquist AK, Daubert JP et al (2000) Efficacy of implantable cardioverter–defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 342(6):365–373

Article  CAS  PubMed  Google Scholar 

Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P et al (2014) 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy. Polish Heart J (Kardiologia Polska) 72(11):1054–1126

Article  Google Scholar 

Members WC, Ommen SR, Ho CY, Asif IM, Balaji S, Burke MA et al (2024) 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 83(23):2324–2405

Article  Google Scholar 

Maron BJ, Dearani JA, Ommen SR, Maron MS, Schaff HV, Nishimura RA et al (2015) Low operative mortality achieved with surgical septal myectomy: role of dedicated hypertrophic cardiomyopathy centers in the management of dynamic subaortic obstruction. J Am Coll Cardiol 66(11):1307–1308

Article  PubMed  Google Scholar 

Hodges K, Rivas CG, Aguilera J, Borden R, Alashi A, Blackstone EH et al (2019) Surgical management of left ventricular outflow tract obstruction in a specialized hypertrophic obstructive cardiomyopathy center. J Thorac Cardiovasc Surg 157(6):2289–2299

Article  PubMed  Google Scholar 

Hong JH, Schaff HV, Nishimura RA, Abel MD, Dearani JA, Li Z et al (2016) Mitral regurgitation in patients with hypertrophic obstructive cardiomyopathy: implications for concomitant valve procedures. J Am Coll Cardiol 68(14):1497–1504

Article  PubMed  Google Scholar 

Nguyen A, Schaff HV, Nishimura RA, Dearani JA, Geske JB, Lahr BD et al (2018) Does septal thickness influence outcome of myectomy for hypertrophic obstructive cardiomyopathy? Eur J Cardiothorac Surg 53(3):582–589

Article  PubMed  Google Scholar 

Balaram SK, Ross RE, Sherrid MV, Schwartz GS, Hillel Z, Winson G et al (2012) Role of mitral valve plication in the surgical management of hypertrophic cardiomyopathy. Ann Thorac Surg 94(6):1990–1998

Article  PubMed  Google Scholar 

Rastegar H, Boll G, Rowin EJ, Dolan N, Carroll C, Udelson JE et al (2017) Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: the Tufts experience. Ann Cardiothorac Surg 6(4):353

Article  PubMed  PubMed Central  Google Scholar 

Vriesendorp PA, Schinkel AF, Soliman OI, Kofflard MJ, de Jong PL, van Herwerden LA et al (2015) Long-term benefit of myectomy and anterior mitral leaflet extension in obstructive hypertrophic cardiomyopathy. Am J Cardiol 115(5):670–675

Article  PubMed  Google Scholar 

Ferrazzi P, Spirito P, Iacovoni A, Calabrese A, Migliorati K, Simon C et al (2015) Transaortic chordal cutting: mitral valve repair for obstructive hypertrophic cardiomyopathy with mild septal hypertrophy. J Am Coll Cardiol 66(15):1687–1696

Article  PubMed  Google Scholar 

Minakata K, Dearani JA, Nishimura RA, Maron BJ, Danielson GK (2004) Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae. J Thorac Cardiovasc Surg 127(2):481–489

Article  PubMed  Google Scholar 

Kaple RK, Murphy RT, DiPaola LM, Houghtaling PL, Lever HM, Lytle BW et al (2008) Mitral valve abnormalities in hypertrophic cardiomyopathy: echocardiographic features and surgical outcomes. Ann Thorac Surg 85(5):1527–35.e2

Article  PubMed  Google Scholar 

Schoendube FA, Klues HG, Reith S, Flachskampf FA, Hanrath P, Messmer BJ (1995) Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. Circulation 92(9):122–127

Article  Google Scholar 

Maron MS, Masri A, Nassif ME, Barriales-Villa R, Arad M, Cardim N et al (2024) Aficamten for symptomatic obstructive hypertrophic cardiomyopathy. N Engl J Med 390:1849–1861

Article  CAS  PubMed  Google Scholar 

Dorobantu LF, Iosifescu TA, Ticulescu R, Greavu M, Alexandrescu M, Dermengiu A et al (2022) Transaortic shallow septal myectomy and cutting of secondary fibrotic mitral valve chordae—a 5-year single-center experience in the treatment of hypertrophic obstructive cardiomyopathy. J Clin Med 11(11):3